SOLIGENIX, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
SOLIGENIX, INC. (SNGX) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $0 for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-11.
Discontinued › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2014-08-11
- SOLIGENIX, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2014-06-30 was $0.00.
- SOLIGENIX, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2014-03-31 was $0.00.
- SOLIGENIX, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2013-06-30 was $0.00.
- SOLIGENIX, INC. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2013-03-31 was $0.00.
- SOLIGENIX, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2013 was $0.00.
- SOLIGENIX, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2012 was $0.00.
- SOLIGENIX, INC. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2011 was $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month |
|---|---|---|---|---|
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | ||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-03-26 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2014-08-11 | $0.00 derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2014-05-12 | $0.00 derived: sum of 3 quarters · filed 2014-05-12 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $0.00 derived: sum of 2 quarters · filed 2014-03-26 | $0.00 10-K · filed 2014-03-26 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | ||
| 2012-06-30 | $0.00 10-Q · filed 2012-08-10 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $0.00 derived: sum of 2 quarters · filed 2013-02-26 | $0.00 10-K · filed 2013-02-26 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |